Evidence map›Paper›PMID 22428449›Full record

ReviewMissouri medicine

Rational use of blood tests in the evaluation of rheumatic diseases.

Chokkalingam Siva, Emily C Larson, Mark Barnett

Open access · greenAbstract readReview
In one paragraph

Review in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Systemic investigations in dry eye disease.Indian journal of ophthalmology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chokkalingam SivaUniversity of Missouri School of Medicine, Division of Immunology and Rheumatology, USA. sivac@health.missouri.edu
Emily C Larson
Mark Barnett
University of Missouri Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many blood tests used in the evaluation of rheumatic diseases are non-specific and should not be ordered and interpreted in isolation. False positive results can lead to inappropriate therapies with serious adverse events while false negatives may steer the provider to incorrect diagnoses. Relying on blood tests alone without considering the clinical context should be avoided.

Indexed as

Hematologic TestsHumansRheumatic DiseasesSerologic Tests

Identifiers

PMID22428449
PMCPMC6181688
OpenAlexW2414021083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.